USE OF HYPOMETHYLATING AGENTS IN RELAPSED/REFRACTORY PEDIATRIC ACUTE MYELOID LEUKEMIA

被引：0
|
作者：
Sabnis, Himalee [1 ]
Raikar, Sunil [1 ]
Bennett, Anna [1 ]
MacDonald, Kelly [1 ]
Watkins, Benjamin [1 ]
Woods, William [1 ]
Keller, Frank [1 ]
机构：
[1] Childrens Healthcare Atlanta, Atlanta, GA USA
来源：
PEDIATRIC BLOOD & CANCER | 2021年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
81
引用
收藏
页码：S52 / S53
页数：2
相关论文
共 50 条
  • [21] Emerging agents and regimens for treatment of relapsed and refractory acute myeloid leukemia
    Longzhen Cui
    Yan Liu
    Yifan Pang
    Tingting Qian
    Liang Quan
    Zhiheng Cheng
    Yifeng Dai
    Xu Ye
    Ying Pang
    Jinlong Shi
    Xiaoyan Ke
    Depei Wu
    Lin Fu
    Cancer Gene Therapy, 2020, 27 : 1 - 14
  • [22] Venetoclax combination therapy with hypomethylating agents in young adults with relapsed/refractory acute myeloid leukaemia
    Baez-Gutierrez, Nerea
    Rodriguez-Ramallo, Hector
    Antonia-Perez Moreno, Maria
    Arboli, Eduardo-Rodriguez
    Abdel-Kader Martin, Laila
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2021, 12
  • [23] Relapsed and Refractory Pediatric Acute Myeloid Leukemia: Current and Emerging Treatments
    Davila, Jennifer
    Slotkin, Emily
    Renaud, Thomas
    PEDIATRIC DRUGS, 2014, 16 (02) : 151 - 168
  • [24] Relapsed and Refractory Pediatric Acute Myeloid Leukemia: Current and Emerging Treatments
    Jennifer Davila
    Emily Slotkin
    Thomas Renaud
    Pediatric Drugs, 2014, 16 : 151 - 168
  • [25] Venetoclax with Hypomethylating Agents or Low-Dose Cytarabine for Relapsed/Refractory Acute Myeloid Leukemia in a Real-Life Setting
    Piccini, Matteo
    Pilerci, Sofia
    Scappini, Barbara
    Bencini, Sara
    Peruzzi, Benedetta
    Caporale, Roberto
    Signori, Leonardo
    Fabiana, Pancani
    Maria, Vannucchi Alessandro
    Gianfaldoni, Giacomo
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S289 - S289
  • [26] Outcomes of Relapsed or Refractory Acute Myeloid Leukemia after Frontline Hypomethylating Agent with Venetoclax Regimens
    Maiti, Abhishek
    Rausch, Caitlin R.
    Cortes, Jorge E.
    Pemmaraju, Naveen
    Daver, Naval G.
    Ravandi, Farhad
    Garcia-Manero, Guillermo
    Borthakur, Gautam M.
    Naqvi, Kiran
    Ohanian, Maro
    Short, Nicholas J.
    Alvarado, Yesid
    Benton, Christopher B.
    Benton, Christopher B.
    Kadia, Tapan M.
    Takahashi, Koichi
    Yilmaz, Musa E.
    Jain, Nitin
    Kornblau, Steven M.
    Bravo, Guillermo Montalban
    Sasaki, Koji
    Andreeff, Michael
    Bose, Prithviraj
    Ferrajoli, Alessandra
    Issa, Ghayas C.
    Jabbour, Elias
    Masarova, Lucia
    Rytting, Michael E.
    Thompson, Philip A.
    Wang, Sa A.
    Konoplev, Sergej
    Chen, Zhining
    Goswami, Maitrayee
    Maduike, Rita
    Guerrero, Julio A.
    Zhang, Qi
    Cavazos, Antonio
    Ma, Helen
    Bivins, Carol A.
    Wade, Allison
    Adewale, Shadiat L.
    Tse, Susan
    Thomas, Robin
    Vaughan, Kenneth
    Pierce, Sherry A.
    Ning, Jing
    Qiao, Wei
    Welch, John S.
    Kantarjian, Hagop M.
    Konopleva, Marina Y.
    BLOOD, 2019, 134
  • [27] A Successful Bridge Therapy Combining Hypomethylating Agents with Venetoclax for Adult Patients with Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia
    Bang, Su-Yeon
    Park, Silvia
    Kwag, Daehun
    Lee, Jong Hyuk
    Min, Gi-June
    Park, Sung-Soo
    Yoon, Jae-Ho
    Lee, Sung-Eun
    Cho, Byung-Sik
    Eom, Ki-Seong
    Kim, Yoo-Jin
    Lee, Seok
    Min, Chang-Ki
    Cho, Seok-Goo
    Lee, Jong Wook
    Kim, Hee-Je
    CANCERS, 2023, 15 (06)
  • [28] Efficacy and safety of venetoclax plus hypomethylating agents in relapsed/refractory acute myeloid leukemia: a multicenter real-life experience
    Angotzi, Francesco
    Lessi, Federica
    Leoncin, Matteo
    Fili, Carla
    Endri, Mauro
    Lico, Albana
    Visentin, Andrea
    Pravato, Stefano
    Candoni, Anna
    Trentin, Livio
    Gurrieri, Carmela
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [29] Hypomethylating Agents and Venetoclax for Acute Myeloid Leukemia Relapsed After Hematopoietic Stem Cell Transplant
    Ionescu, Filip
    David, Jerel C.
    Ravichandran, Apoorva
    Sallman, David A.
    Sweet, Kendra
    Komrokji, Rami S.
    Chan, Onyee
    Kuykendall, Andrew
    Padron, Eric
    Faramand, Rawan
    Bejanyan, Nelli
    Khimani, Farhad
    Elmariah, Hany
    Pidala, Joseph
    Mishra, Asmita
    Perez, Lia
    Nishihori, Taiga
    Lancet, Jeffrey E.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (06): : 400 - 406
  • [30] Increased expression of CD70 in relapsed acute myeloid leukemia after hypomethylating agents
    Marques-Piubelli, Mario L.
    Kumar, Bijender
    Basar, Rafet
    Panowski, Siler
    Srinivasan, Surabhi
    Norwood, Kevin
    Prashad, Sacha
    Szenes, Victoria
    Balakumaran, Arun
    Arandhya, Akanksha
    Lu, Wei
    Khan, Khaja
    Duenas, Daniela
    McAllen, Salome
    Gomez, Javier A.
    Burks, Jared K.
    Acharyal, Sunil
    Borthakur, Gautam
    Wang, Wei-Lien
    Wang, Wei
    Wang, Sa
    Solis, Luisa M.
    Marin, David
    Rezvani, Katayoun
    Daher, May
    Vega, Francisco
    VIRCHOWS ARCHIV, 2024, 485 (05) : 937 - 941
12345